Joel Lewis owns 0.83% of Galectin Therapeutics
834,592 shares as of the January 16, 2026 filing, worth $3M at the latest close.
GALT · $365M market capGet an email when Joel Lewis’s stake moves.
Free.
The stake
0.83%
worth $3M at the latest close
Stake rank
#2,339
by dollar value of the stake
Last sale
286 days ago
Jan 6, 2026
Last buy
908 days ago
Apr 24, 2024 · $3,390
Joel Lewis owns 0.83% of GALECTIN THERAPEUTICS INC: 834,592 of 100,849,644 shares, worth about $3M at the 2026-10-16 close. The stake has moved from 0.14% in 2017 to 0.83% on 2026-08-06, across 2 sales and 7 purchases that moved it since 2016. The last trade that moved it was a planned sale of $321,134 on 2026-01-06.
How the stake is held
as of the Jan 6, 2026 filing
SHARES
OF THE STAKE
COMMON STOCK · stated Jan 6, 2026 · Form 4 ↗
HELD DIRECTLY
832,592
99.8%
HELD INDIRECTLY · as USTA custodian for a minor child
2,000
0.2%
THE STAKE
834,592
0.83%